Brain tumor classification of virtual NMR voxels based on realistic blood vessel-induced spin dephasing using support vector machines.

Journal: NMR in biomedicine
Published Date:

Abstract

Remodeling of tissue microvasculature commonly promotes neoplastic growth; however, there is no imaging modality in oncology yet that noninvasively quantifies microvascular changes in clinical routine. Although blood capillaries cannot be resolved in typical magnetic resonance imaging (MRI) measurements, their geometry and distribution influence the integral nuclear magnetic resonance (NMR) signal from each macroscopic MRI voxel. We have numerically simulated the expected transverse relaxation in NMR voxels with different dimensions based on the realistic microvasculature in healthy and tumor-bearing mouse brains (U87 and GL261 glioblastoma). The 3D capillary structure in entire, undissected brains was acquired using light sheet fluorescence microscopy to produce large datasets of the highly resolved cerebrovasculature. Using this data, we trained support vector machines to classify virtual NMR voxels with different dimensions based on the simulated spin dephasing accountable to field inhomogeneities caused by the underlying vasculature. In prediction tests with previously blinded virtual voxels from healthy brain tissue and GL261 tumors, stable classification accuracies above 95% were reached. Our results indicate that high classification accuracies can be stably attained with achievable training set sizes and that larger MRI voxels facilitated increasingly successful classifications, even with small training datasets. We were able to prove that, theoretically, the transverse relaxation process can be harnessed to learn endogenous contrasts for single voxel tissue type classifications on tailored MRI acquisitions. If translatable to experimental MRI, this may augment diagnostic imaging in oncology with automated voxel-by-voxel signal interpretation to detect vascular pathologies.

Authors

  • Artur Hahn
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Julia Bode
    Schaller Research Group at the University of Heidelberg and the German Cancer Research Center (DKFZ), Molecular Mechanisms of Tumor Invasion, Heidelberg, Germany.
  • Sarah Schuhegger
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Thomas Krüwel
    Schaller Research Group at the University of Heidelberg and the German Cancer Research Center (DKFZ), Molecular Mechanisms of Tumor Invasion, Heidelberg, Germany.
  • Volker J F Sturm
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Ke Zhang
    Center for Radiation Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou 310001, China.
  • Johann M E Jende
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Björn Tews
    Schaller Research Group at the University of Heidelberg and the German Cancer Research Center (DKFZ), Molecular Mechanisms of Tumor Invasion, Heidelberg, Germany.
  • Sabine Heiland
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Martin Bendszus
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Michael O Breckwoldt
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Christian H Ziener
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Felix T Kurz
    Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.